Sodium 4-amino-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-5-yl hydrogendiphosphate CAS: 54394-90-0

Cov tshuaj "sodium 4-amino-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-5-yl hydrogendiphosphate" zoo li yog cov lus piav qhia txog tshuaj lom neeg ntawm adenosine diphosphate (ADP). ADP yog ib qho tseem ceeb hauv kev ua haujlwm ntawm lub hlwb thiab kev hloov pauv zog. Nws ua haujlwm ua tus ua ntej rau ATP (adenosine triphosphate), lub zog tseem ceeb ntawm lub hlwb.

Cov haujlwm thiab daim ntawv thov ntawm ADP muaj ntau yam thiab suav nrog nws txoj kev koom tes hauv kev ua pa ntawm tes thiab kev hloov pauv lub zog. Tsis tas li ntawd, ADP muaj daim ntawv thov hauv kev tshawb fawb biochemical, kev tsim tshuaj, thiab ua lub hom phiaj rau cov tshuaj. Nws qhov tseem ceeb hauv cov ntsiab lus ntawm cov kab mob plawv thiab thrombosis tau ua rau muaj kev tsim cov ADP receptor antagonists, uas yog siv ua cov tshuaj antiplatelet los tiv thaiv cov ntshav txhaws.